BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27252509)

  • 1. HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?
    Meijerink JP; Canté-Barrett K; Vroegindeweij E; Pieters R
    Haematologica; 2016 Jun; 101(6):654-6. PubMed ID: 27252509
    [No Abstract]   [Full Text] [Related]  

  • 2. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
    Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
    Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
    Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study.
    Matlawska-Wasowska K; Kang H; Devidas M; Wen J; Harvey RC; Nickl CK; Ness SA; Rusch M; Li Y; Onozawa M; Martinez C; Wood BL; Asselin BL; Chen IM; Roberts KG; Baruchel A; Soulier J; Dombret H; Zhang J; Larson RS; Raetz EA; Carroll WL; Winick NJ; Aplan PD; Loh ML; Mullighan CG; Hunger SP; Heerema NA; Carroll AJ; Dunsmore KP; Winter SS
    Leukemia; 2016 Sep; 30(9):1909-12. PubMed ID: 26952838
    [No Abstract]   [Full Text] [Related]  

  • 5. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
    Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
    Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAP1L1-MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T-cell acute lymphoblastic leukaemia.
    Bond J; Touzart A; Cieslak A; Trinquand A; Marchand T; Escoffre M; Contet A; Muller M; Schmitt C; Fest T; Asnafi V; Macintyre E
    Br J Haematol; 2016 Aug; 174(3):470-3. PubMed ID: 26455581
    [No Abstract]   [Full Text] [Related]  

  • 7. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypermethylation of CpG island in promoter region of MEIS1 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
    Jia JS; Spicuglia S
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3835-40. PubMed ID: 24548444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma/leukemia.
    Xi Y; Li J; Zan L; Wang J; Wang G; Ning Y
    Hum Pathol; 2013 Jun; 44(6):1011-6. PubMed ID: 23260326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia.
    van Grotel M; van den Heuvel-Eibrink MM; van Wering ER; van Noesel MM; Kamps WA; Veerman AJ; Pieters R; Meijerink JP
    Pediatr Blood Cancer; 2008 Dec; 51(6):737-40. PubMed ID: 18683236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
    Asnafi V; Ferrier P
    Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel insights on TLX1 function in T-ALL pave the way towards differentiation therapy.
    De Keersmaecker K
    Haematologica; 2012 Jun; 97(6):795. PubMed ID: 22665526
    [No Abstract]   [Full Text] [Related]  

  • 13. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
    Samra B; Alotaibi AS; Short NJ; Khoury JD; Ravandi F; Garris R; Jain N; Konopleva M; Kantarjian H; Jabbour E
    Am J Hematol; 2020 Sep; 95(9):E245-E247. PubMed ID: 32501545
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.
    Attarbaschi A; Pisecker M; Inthal A; Mann G; Janousek D; Dworzak M; Pötschger U; Ullmann R; Schrappe M; Gadner H; Haas OA; Panzer-Grümayer R; Strehl S;
    Br J Haematol; 2010 Jan; 148(2):293-300. PubMed ID: 19821827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
    Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute T cells lymphoblastic leukemia with a t(1;19)(q23;p13) and E2A-PBX1 in an adult: one case report and literature review].
    He GS; Zhang XH; Yao L; Zhang R; Chen ZX; Wu DP; Sun AN; Jin ZM; Qiu HY; Hu XH
    Zhonghua Xue Ye Xue Za Zhi; 2009 Oct; 30(10):675-7. PubMed ID: 19954663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia.
    Bains T; Heinrich MC; Loriaux MM; Beadling C; Nelson D; Warrick A; Neff TL; Tyner JW; Dunlap J; Corless CL; Fan G
    Leukemia; 2012 Sep; 26(9):2144-6. PubMed ID: 22425895
    [No Abstract]   [Full Text] [Related]  

  • 20. Early T-cell precursor leukemia/lymphoma in adults and children.
    Allen A; Sireci A; Colovai A; Pinkney K; Sulis M; Bhagat G; Alobeid B
    Leuk Res; 2013 Sep; 37(9):1027-34. PubMed ID: 23827350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.